激活突变驱动人类MEK1激酶使用变速机制
Keshav Patil1, Yiming Wang1, Zhangtao Chen2
1Department of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, U.S.A.
The Biochemical journal
|October 23, 2023
概括
促进癌症的激酶突变通过稳定活性状态来改变MEK1的功能. 了解这些变化揭示了突变如何影响疾病和药物反应,提供了对激酶调节的见解.
科学领域:
- 生物化学和结构生物学.
- 计算生物物理学的计算生物物理.
- 分子动力学分子动力学
背景情况:
- 激酶突变驱动癌症和RAS病变,但它们的机械学分类缺乏.
- 了解突变如何改变激酶结构和功能对于治疗向至关重要.
- 人类MEK1激酶是RAS/MAPK通路的一部分,在癌症和发育障碍中经常发生突变.
研究的目的:
- 探索癌症相关突变如何影响人类MEK1激酶的原子分辨率.
- 为了计算地绘制突变MEK1.1的结构稳定性和自由能量景观.
- 将这些计算发现与实验确定的突变潜力联系起来.
主要方法:
- 利用增强的采样模拟和自由能源计算.
- 为突变的MEK1系统计算划分的自由能源景观.
- 分析了结网络的变化和残留水平的相关性.
主要成果:
- 突变逐渐稳定了MEK1的活性类构造,同时破坏了非活性类状态的稳定.
- 自由能量景观显示了每个突变的不同形状稳定性.
- 突变改变了内部分子相关性,影响了MEK1的激活模式,就像变速机制一样.
结论:
- 突变利用构造性可塑性和键网络来调节MEK1活动.
- 该研究定义了MEK1激活,链接结构,动态和功能的分子基础.
- 这项工作增强了对MEK1调节和致癌突变影响的理解.
相关概念视频
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


